share_log

Aravive Analyst Ratings

Aravive Analyst Ratings

Aravive 分析师评级
Benzinga ·  2023/07/21 08:50
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/21/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/17/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/10/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
07/03/2023 922.73% Cantor Fitzgerald $18 → $18 Reiterates Overweight → Overweight
06/05/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
06/05/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/26/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/26/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/25/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/25/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
05/17/2023 922.73% Cantor Fitzgerald → $18 Reiterates Overweight → Overweight
05/11/2023 468.18% EF Hutton → $10 Reiterates Buy → Buy
05/11/2023 581.82% HC Wainwright & Co. → $12 Reiterates Buy → Buy
03/16/2023 581.82% HC Wainwright & Co. $7 → $12 Maintains Buy
02/21/2023 297.73% HC Wainwright & Co. → $7 Reiterates → Buy
02/14/2023 468.18% EF Hutton → $10 Maintains Buy
01/05/2023 468.18% EF Hutton → $10 Initiates Coverage On → Buy
11/14/2022 13.64% Piper Sandler $6 → $2 Maintains Overweight
10/25/2022 297.73% HC Wainwright & Co. $26 → $7 Maintains Buy
06/03/2022 752.27% Roth Capital → $15 Initiates Coverage On → Buy
03/08/2021 1377.27% BTIG → $26 Initiates Coverage On → Buy
09/18/2020 — William Blair Initiates Coverage On → Outperform
07/23/2020 1377.27% HC Wainwright & Co. $15 → $26 Maintains Buy
03/27/2020 752.27% HC Wainwright & Co. $25 → $15 Maintains Buy
12/20/2019 1320.45% HC Wainwright & Co. $31 → $25 Maintains Buy
12/10/2019 1604.55% Cantor Fitzgerald → $30 Initiates Coverage On → Overweight
11/20/2019 1661.36% HC Wainwright & Co. $18 → $31 Reiterates → Buy
11/19/2019 1945.45% Piper Sandler $15 → $36 Maintains Overweight
10/10/2019 922.73% HC Wainwright & Co. → $18 Initiates Coverage On → Buy
05/13/2019 468.18% Piper Sandler → $10 Initiates Coverage On → Overweight
04/09/2019 695.45% Wedbush → $14 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
07/21/2023 922.73% 康托·菲茨杰拉德 →$18 重申 超重→超重
07/17/2023 922.73% 康托·菲茨杰拉德 →$18 重申 超重→超重
07/10/2023 922.73% 康托·菲茨杰拉德 →$18 重申 超重→超重
07/03/2023 922.73% 康托·菲茨杰拉德 $18→$18 重申 超重→超重
06/05/2023 581.82% HC Wainwright公司 →$12 重申 购买→购买
06/05/2023 468.18% EF Hutton →$10 重申 购买→购买
2023年05月26日 468.18% EF Hutton →$10 重申 购买→购买
2023年05月26日 581.82% HC Wainwright公司 →$12 重申 购买→购买
2023年05月25日 468.18% EF Hutton →$10 重申 购买→购买
2023年05月25日 581.82% HC Wainwright公司 →$12 重申 购买→购买
2023年05月17日 922.73% 康托·菲茨杰拉德 →$18 重申 超重→超重
2023年05月11日 468.18% EF Hutton →$10 重申 购买→购买
2023年05月11日 581.82% HC Wainwright公司 →$12 重申 购买→购买
03/16/2023 581.82% HC Wainwright公司 $7→$12 维护 买
02/21/2023 297.73% HC Wainwright公司 →$7 重申 →购买
02/14/2023 468.18% EF Hutton →$10 维护 买
01/05/2023 468.18% EF Hutton →$10 开始承保 →购买
2022年11月14日 13.64% 派珀·桑德勒 $6→$2 维护 超重
2022年10月25日 297.73% HC Wainwright公司 $26→$7 维护 买
06/03/2022 752.27% 罗斯资本 →$15 开始承保 →购买
03/08/2021 1377.27% BTIG →$26 开始承保 →购买
09/18/2020 - 威廉·布莱尔 开始承保 →跑赢大盘
07/23/2020 1377.27% HC Wainwright公司 $15→$26 维护 买
03/27/2020 752.27% HC Wainwright公司 $25→$15 维护 买
2019年12月20日 1320.45% HC Wainwright公司 $31→$25 维护 买
2019年12月10日 1604.55% 康托·菲茨杰拉德 →$30 开始承保 →超重
2019年11月20日 1661.36% HC Wainwright公司 $18→$31 重申 →购买
2019年11月19日 1945.45% 派珀·桑德勒 $15→$36 维护 超重
2019年10月10日 922.73% HC Wainwright公司 →$18 开始承保 →购买
2019年05月13日 468.18% 派珀·桑德勒 →$10 开始承保 →超重
2019年09月04日 695.45% 韦德布什 →$14 开始承保 →跑赢大盘

What is the target price for Aravive (ARAV)?

Aravive(ARAV)的目标价是多少？

The latest price target for Aravive (NASDAQ: ARAV) was reported by Cantor Fitzgerald on July 21, 2023. The analyst firm set a price target for $18.00 expecting ARAV to rise to within 12 months (a possible 922.73% upside). 19 analyst firms have reported ratings in the last year.

康托·菲茨杰拉德于2023年7月21日报道了Aravive(纳斯达克代码：ARIV)的最新目标价。这家分析公司将目标价定为18美元，预计ARAV值将在12个月内上涨(可能上涨922.73%)。去年有19家分析公司公布了评级。

What is the most recent analyst rating for Aravive (ARAV)?

分析师对Aravive(ARAV)的最新评级是多少？

The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by Cantor Fitzgerald, and Aravive reiterated their overweight rating.

分析师对Aravive(纳斯达克代码：ARIV)的最新评级由康托·菲茨杰拉德提供，Aravive重申其增持评级。

When is the next analyst rating going to be posted or updated for Aravive (ARAV)?

Aravive(ARAV)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on July 21, 2023 so you should expect the next rating to be made available sometime around July 21, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aravive的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aravive的上一次评级是在2023年7月21日提交的，所以你应该预计下一次评级将在2024年7月21日左右提供。

Is the Analyst Rating Aravive (ARAV) correct?

分析师对Aravive(ARAV)的评级正确吗？

While ratings are subjective and will change, the latest Aravive (ARAV) rating was a reiterated with a price target of $0.00 to $18.00. The current price Aravive (ARAV) is trading at is $1.76, which is within the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Aravive(ARAV)评级被重申，目标价在0.00美元至18.00美元之间。Aravive(ARAV)目前的交易价格为1.76美元，在分析师的预测范围内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发